Trial Condition(s):

Cystic Fibrosis

Pilot study to compare acarbose (BAY g 5421) with placebo in respect of efficacy and tolerability in patients with cystic fibrosis and pathological glucose tolerance

Bayer Identifier:

Trial_0696

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

November1993

September1995

Phase

Could I receive a placebo?

Products

Acarbose (Precose/Glucobay, BAYG5421)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Locations

Cystic Fibrosis

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

7 Years

25 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information